Outcomes and PSA kinetics after Magnetic Resonance Image-Guided Stereotactic Body Radiotherapy (MRgSBRT) for prostate cancer

Key Points

• Improved PSA kinetics were observed following MRI-guided stereotactic body radiotherapy.
• The study reported significant changes in PSA levels over a defined timeframe post-treatment.
• Observational analysis assessed efficacy using clinical outcome measures in a prostate cancer cohort.
• These findings underscore the potential of MRgSBRT as an effective intervention for prostate cancer.